Global Coalition on Aging Calls for Japan to Lead on Antimicrobial Resistance Issues as President of the G7

Alongside the G7 and the UN Decade of Healthy Ageing, the policy environment is ripe for urgent action on AMR from super-aging Japan.

New York, NEW YORK (December 13, 2022) – The Global Coalition on Aging today announced the release of its roundtable report, “AMR & Japan’s G7 Presidency: A Call for Pull Incentives to Drive Innovation.” The report is based on a small, private roundtable of leaders from the United Kingdom, the United States, and Sweden, alongside Japanese decision-makers and experts.

“Japan has already importantly driven push incentives; now it must implement trial pull incentives at this important moment for the country,” said Michael Hodin, CEO of the Global Coalition on Aging. “Japan has the opportunity to lead the globe in combatting AMR, helping to realize healthy aging for all as part of the UN Decade of Healthy Ageing.”

AMR is a crisis for all of society, but older adults are most at risk, making AMR a critical priority for super-aging Japan, where close to 40% of the population is over 60. Experts at the roundtable identified four critical actions that Japan must take to urgently address AMR as Japan assumes the 2023 G7 Presidency.

  1. Implement a pilot pull incentive to stimulate antibiotic innovation based on best-fit model for Japan, building on the experiences provided by the UK subscription pilot and the U.S. PASTEUR Act.
  2. Build policy guidance on AMR into the Health and Finance Ministers’ meetings and communiques.
  3. Communicate the urgency for AMR policy action through Japan’s G7 Presidency at the Summit level, which will underscore the Health and Finance support for G7 AMR actions.
  4. Invite collaboration and partnership with other countries, both those already leading on AMR action and those seeking inspiration and guidance.

“We must change how we pay for antibiotics. Most new antibiotics are classified as ‘reserve’ by the WHO, which is the right answer for public health, but companies are going bankrupt without anyone using their drug. We should pay for the protective value of antibiotics,” said Kevin Outterson, Executive Director and Principal Investigator, CARB-X. “To compare it to a fire extinguisher, we pay when the extinguisher is installed behind glass, not when we break the glass to put out a fire.”

This is a critical opportunity for Japan’s leadership on the global stage. Following Japan’s G7 leadership, the next High-level Meeting on AMR at the UN General Assembly will take place in September 2024, making Japan uniquely well positioned to both dictate policy priorities and direct political attention ahead of the meeting.

About the Global Coalition on Aging

The Global Coalition on Aging aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. GCOA uniquely brings together global corporations across industry sectors with common strategic interests in aging populations, a comprehensive and systemic understanding of aging, and an optimistic view of its impact. Through research, public policy analysis, advocacy, and strategic communications, GCOA is advancing innovative solutions and working to ensure global aging is a path for fiscally sustainable economic growth, social value creation and wealth enhancement.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.